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Syncope is a sudden transient loss of consciousness and postural tone with spontaneous 
recovery.  Loss of consciousness results from a reduction of blood flow to the reticular activating 
system located in the brain stem. Syncope is an important clinical problem which accounts for 1% of 
hospital admissions and 3% of emergency department visits with a reported mortality and major 
morbidity rate of over 7% [1]. It is often disabling, may cause injury and may be the only warning sign 




Causes of Syncope 
Syncope is a symptom, not a disease, and can 
be classified according to the underlying 
cause. The causes of syncope can be 
classified into six groups including vascular, 
cardiac, neurological, psychogenic, metabolic, 
and syncope of unknown origin. Vascular 
causes of syncope (Table 1) are most 
common, followed by cardiac causes of 
syncope (Table 2). The most common cause 
of syncope in the general population is the 
neurally- mediated syncope (also known as 
neurocardiogenic, vasovagal syncope and as 
“fainting”), followed by primary cardiac 
arrhythmias.  
The causes of syncope are highly age 
dependent [2]. The etiology of syncope in 
children and young adults is most likely related 
to neurocardiogenic syncope, psychiatric 
conversion reactions, and primary arrhythmic 
causes such as Wolff-Parkinson-White (WPW) 
syndrome and long QT interval syndrome 
(LQTS).  
In middle age, neurocardiogenic syncope 
remains the most frequent cause of syncope.  
Common causes of syncope in elderly persons 
include orthostatic hypotension, postprandial 
hypotension, medications, aortic valve 
stenosis, carotid sinus hypersensitivity, and 
bradyarrhythmias (e.g. sick sinus syndrome, 
heart block).  
Other forms of neurocardiogenic syncope (so-
called situational syncope) related to 
deglutition, micturition, defecation, and cough 
are more common in the middle-aged or 
elderly patients than in young patients [3].   
Metabolic causes of syncope are rare, 
accounting for less than 5% of syncopal 
episodes. The most common metabolic 
causes of syncope are hypoglycemia, hypoxia, 
and hyperventilation.  
Table 1: Causes of vascular syncope 
Orthostatic Reflex-mediated 




- Carotid sinus hypersensitivity. 
- Neurally mediated syncope. 
- Glossopharyngeal syncope. 
- Situational (cough, micturition). 
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Table 2: Cardiac causes of syncope. 
Structural Arrhythmogenic 









- Sinus node dysfunction. 
- AV-block. 
Tachyarrhythmias: 
    - Supraventricular arrhythmias. 




Table 3: Features of clinical history distinguishing seizures from syncope: 
- Confusional state following the event (postictal state). 
- Blue face (not becoming pale) during the event. 
- Frothing at the mouth. 
- Aching muscles. 
- Feeling sleepy after the event. 
- Duration of unconsciousness of more than 5 minutes. 
- Tongue biting (strongly suggestive of a seizure). 
- An aura before the episode. 
- Horizontal eye deviation during the episode. 
- Elevated BP and pulse during the episode. 
- A headache following the event. 




Neurocardiogenic syncope is caused by an 
abnormal or exaggerated autonomic response 
to various stimuli, such as standing and 
emotion. The mechanism is poorly understood 
but involves reflex mediated changes in heart 
rate or vascular tone, caused by stimulation of 
the medullary vasodepressor region of the 
brain stem. Stimulation of this region in the 
brain may occur due to activation of various 
receptors, such as the afferent 
mechanocardiac receptors (cardiac C fibers), 
cardiopulmonary baroreceptors, 
gastrointestinal or genitourinary mechano-
receptors [4,5]. When a person stands, 500 to 
800 ml of blood is displaced to the abdomen 
and lower extremities, resulting in an abrupt 
drop in venous return to the heart. This drop 
leads to a decrease in cardiac output and 
stimulation of aortic, carotid, and 
cardiopulmonary receptors, which trigger a 
reflex increase in sympathetic outflow. As a 
result, heart rate, cardiac contractility, and 
vascular resistance increase to maintain a 
stable systemic blood pressure on standing. In 
patients susceptible to neurocardiogenic 
syncope, the reduction in ventricular preload 
(due to venous pooling) and increased 
catecholamine levels lead to a vigorously 
contracting volume-depleted ventricle. It has 
been proposed that vigorous contractions of a 
volume-depleted ventricle lead to activation of 
the cardiac C fibers (nonmyelinated fibers, 
found in the atria, ventricles and pulmonary 
artery).  Stimulation of these afferent C fibers 
leads to a “paradoxical” withdrawal of 
peripheral sympathetic tone and an increase in 
vagal tone, which, in turn causes vasodilation 
and bradycardia. The ultimate clinical 
consequence is syncope or presyncope [1]. 
Cardiac arrhythmias are an important cause of 
neurologic symptoms. Bradyarrhythmia and 
tachyarrhythmia may cause syncope by 
disrupting blood flow to the brain.  
Clinical Features 
Although presentation of neurocardiogenic 
syncope is similar to that of other types of 
syncope, loss of consciousness in patients 
with neurocardiogenic syncope may be 
preceded by prodromata such as nausea, 
diaphoresis, lightheadedness, ringing in the 
ears, blurred vision, headaches, palpitations, 
paraesthesia, and pallor [6,7]. 
 Key clinical features of neurocardiogenic 
syncope are as follow:  
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- It tends to be situational. 
- It is often recurrent during a patient’s 
lifetime. 
- It is often preceded by at least a few 
seconds of prodromal symptoms. 
- It occurs when the patient is in the 
upright position, and is resolved and 
can be aborted by assuming the 
supine position. 
- After recovery, patients with 
neurocardiogenic syncope often 
complain of a “washed out” and tired 
feeling. 
Although neurocardiogenic syncope can be 
seen in any age group, it is most common in 
younger patients with normal cardiac function. 
It tends to be uncommon in patients with 
significant cardiac dysfunction, probably 
because the C fibers are affected by 
myocardial disease [4]. 
Syncope associated with high intensity 
physical activity is a typical presentation of 
hypertrophic cardiomyopathy or 
catecholaminergic ventricular tachycardia. 
 
Diagnostic Evaluation of Syncope 
The primary purpose of evaluating patients 
with syncope is to determine whether the 
patient is at increased risk of death. This 
involves identifying patients with underlying 
heart disease and potentially life-threatening 
arrhythmias.  
1- History and Physical Examination: 
In most patients, the cause of syncope can be 
determined with great accuracy from a careful 
history and physical examination. The history 
is also useful for identifying precipitating 
factors that may increase risk of syncope [8]. 
Assessment of the symptoms and the clinical 
setting may yield clues as to the possible 
cause of the syncope.  
Syncope after cough, defecation, and 
micturition suggests situational syncope; and 
syncope after pain, fear, or noxious stimuli 
suggests neurocardiogenic syncope [5]. 
Carotid sinus syncope may occur with rotation 
or turning of the head or pressure on the 
carotid sinus (for example, carotid massage, 
shaving, tight collars or neckwear). 
History of tonic-clonic seizure-like activity is 
associated with both cardiac and neurological 
causes of syncope [6].  
Auras, premonitions, postictal confusion, and 
focal neurological signs and symptoms 
suggest a neurological cause of syncope 
(Table 3). 
Episodes of neurocardiogenic syncope are 
typically associated with post-episode fatigue 
and weakness, whereas the absence of a 
prodrome is consistent with cardiac syncope 
[9].  
Vertebral basilar insufficiency should be 
considered as the cause of syncope if syncope 
occurs in association with other symptoms of 
brainstem ischemia such as diplopia, tinnitus, 
focal weakness or sensory loss, vertigo or 
dysarthria.  
A history of myocardial infarction or previously 
repaired congenital cardiac defect raises the 
possibility of ventricular arrhythmias. 
It is also useful to obtain careful history from 
witnesses who may have been present during 
the episode of syncope.  
A careful physical examination is extremely 
useful in the evaluation of syncope. Orthostatic 
hypotension, autonomic dysfunction, and 
some cardiac defects can be identified by 
measuring blood pressure and pulse rate in 
the upper and lower extremities both in supine 
and upright positions. Carotid bruits should 
raise the possibility of compromised cerebral 
blood flow and underlying carotid artery 
disease. Abnormalities of visual fields, speech, 
motor strength, and sensation, tremor, and gait 
disturbances suggest an underlying 
neurological disorder. 
Physical examination may suggest the 
presence of pulmonary hypertension, left 
ventricular dysfunction, valvular heart disease, 
or other forms of structural heart disease. 
2- The electrocardiogram (ECG):  
The ECG provides important information about 
the cardiac rhythm and the atrioventricular 
(AV) conduction.  
Specific findings that can identify the probable 
cause of syncope include QT prolongation 
(LQTS), the presence of a short PR interval 
and delta waves (WPW syndrome), the 
presence of a right bundle branch block and 
ST segment elevation (Brugada syndrome), 
evidence of an acute myocardial infarction, or 
inverted T waves in the right precordial leads 
(arrhythmogenic right ventricular dysplasia).   
3- Echocardiography: 
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 It is an excellent tool to identify underlying 
structural heart disease, including valvular 
heart disease and cardiomyopathies.  
4- Exercise stress:  
It should be performed in patients with 
unexplained syncope, especially if the episode 
was related to exertion. This test provides the 
opportunity to monitor pulse and blood 
pressure (BP) responses to exercise. A drop of 
BP or failure of BP to rise in response to 
exercise raises the question of severe 
coronary artery disease or hypertrophic 
obstructive cardiomyopathy.  
5- Noninvasive ambulatory ECG monitoring: 
It allows for the diagnosis of cardiac rhythm 
disturbances and the correlation of symptoms 
with the cardiac rhythm. The type and duration 
of ambulatory ECG monitoring is dictated by 
the frequency of symptoms. The gold standard 
for the diagnosis of an arrhythmic cause of 
syncope is ECG documentation of the rhythm 
disturbances at the time of symptoms.  
6- Tilt table testing (TTT):   
This is a useful test in establishing the 
diagnosis of neurocardiogenic syncope. A 
positive TTT (i.e. a study that reproduces the 
patient’s syncope) identifies a patient who is 
prone to neurocardiogenic syncope [4]. 
Nevertheless, there have been serious 
questions about the sensitivity, specificity and 
diagnostic yield of this test [11,12]. 
In a patient of any age with an otherwise 
normal evaluation who has a negative TTT, 
the most likely diagnosis is still 
neurocardiogenic syncope. In patients with a 
malignant episode of syncope, it may be more 
important to rule out other causes of syncope 
such as cardiac arrhythmias than it is to 
perform a TTT. 
7- Electrophysiological testing (EPS):  
It involves placement of Transvenous 
catheters/wires within the heart to assess 
sinus node function, AV conduction, and 
susceptibility to supraventricular and 
ventricular tachycardias. Invasive EP testing is 
indicated in syncopal patients who are found 
to have a previous myocardial infarction, poor 
left ventricular function (left ventricular ejection 
fraction of less than 40%), or nonsustained 
ventricular tachycardia.   
Approximately 30% of patients with syncope 
referred for EPS to evaluate syncope of 
unknown origin have a presumptive diagnosis 
established. A negative EPS has generally 
been considered predictive of a low risk of 
sudden death. In patients with an otherwise 
normal evaluation for syncope, the yield of 
EPS is low (approximately 3%) and, therefore, 
this test is not routinely recommended [13]. 
8- Neurological Evaluation: 
Syncope as an isolated symptom rarely has a 
neurological cause. Neurological causes of 
syncope are established in less than 5% of 
patients with syncope.  Neurological causes of 
syncope should be pursued only if suggested 
by history or physical examination.  
Seizure disorders are the most common 
neurological cause of episodic 
unresponsiveness. An electroencephalogram 
can confirm seizure disorders.  It must be 
noted here that cardiac syncope can be 
accompanied by upward gaze deviation, 
asynchronous myoclonic jerks, and brief 
automatisms that result from global cerebral 
hypoperfusion and are not an indication for a 
neurological evaluation. 
Focal neurological signs such as diplopia, limb 
weakness, sensory deficits, or speech 
difficulties are indications for a neurological 
evaluation. Current guidelines for the 
evaluation of syncope suggest that EEGs be 
only obtained when there is a relatively high 
likelihood of seizure disorder. CT and 
magnetic resonance imaging (MRI) should be 
avoided in patients with uncomplicated 
syncope [14]. 
Treatment 
The approach to treatment of a patient with 
syncope depends largely on the diagnosis 
(cause) that is established.  In the elderly, 
multiple causes of syncope frequently coexist 
and need to be addressed. Emphasis should 
be given to the impact of polypharmacy, 
orthostatic intolerance, autonomic dysfunction, 
and carotid sinus hypersensitivity, particularly 
in elderly patients. 
1- Syncope in the patient with a normal 
Evaluation 
Although many life-threatening clinical entities 
are less likely in the presence of a normal 
evaluation, the possibility of neurocardiogenic 
syncope, carotid sinus hypersensitivity, 
paroxysmal bradyarrhythmias and 
tachyarrhythmia and myriad noncardiac 
causes of syncope remains [3]. 
In the absence of underlying heart disease, 
syncope is not associated with excess 
mortality. The main risk is related to physical 
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harm that may occur if the patient has 
recurrent syncope.  
The mainstay of management of patients with 
neurocardiogenic syncope is education of the 
patient to avoid situations that predispose to 
syncope (e.g., dehydration, stress, alcohol 
consumption, prolonged standing, and 
extremely warm environments). This should 
also include anxiety management and coping 
skills, and reassuring the patient that this is a 
benign condition. 
It has been found that the administration of 
beta-blockers or disopyramide is often 
effective in preventing neurocardiogenic 
syncope [15]. Although it may seem paradoxic 
to prescribe beta blockers for patients whose 
syncope is often accompanied by significant 
bradycardia, using beta blockers makes sense 
when one considers that hypersympathetic 
tone is necessary to engage the cardiac C 
fibers. Disopyramide has a strong vagolytic 
effect, but more importantly, it has a direct 
negative inotropic effect on the heart, 
presumably inhibiting C fiber stimulation. It is 
not considered first line treatment because of 
the risk of proarrhythmic and anticholinergic 
adverse effects.  Midodrine, an alpha agonist, 
has been shown to be effective in several 
randomized trials. 
In most patients with neurocardiogenic 
syncope, a fall in blood pressure precedes 
bradycardia; therefore, cardiac pacing is often 
ineffective in most patients. However, dual 
chamber pacing may be effective in reducing 
symptoms if there is a large cardioinhibitory 
component [7].  
 
2- Syncope in the patient with cardiac 
disease: 
Syncope in patients with underlying heart 
disease is associated with a high rate of 
mortality.                                                                  
The appropriate treatment for patients with 
syncope related to advanced AV block or sick 
sinus syndrome is permanent pacing. The 
treatment of a patient with syncope related to 
WPW syndrome would probably involve 
catheter ablation of the accessory pathway. 
Treatment of patients with syncope related to 
ventricular tachycardia and underlying 
ischemic cardiomyopathy would probably 
involve placement of an implantable 
cardioverter defibrillator (ICD) and/or 
revascularization. Implantable defibrillator 
therapy is also effective in high-risk patients 
with hypertrophic cardiomyopathy [16], 
nonischemic dilated cardiomyopathy, long QT 
syndrome [17], Brugada syndrome and in 
patients with arrhythmogenic right ventricular 
dysplasia [18]. Treatment of patients with 
syncope related to critical aortic valve stenosis 
would involve aortic valve replacement with or 
without coronary revascularization. 
Conclusions 
Syncope is an important clinical problem and 
is associated with considerable morbidity. 
Neurocardiogenic syncope is the most 
common cause of syncope and is generally 
considered a benign condition, although 
frequent and recurrent episodes can 
negatively affect quality of life.  Syncope can 
be a precursor to sudden death, particularly in 
patients with underlying heart disease. 
Therefore, the primary purpose of the 
evaluation of the patient with syncope should 
be to determine whether the patient is at 
increased risk for death. This involves 
identifying patients with underlying heart 
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